Print

Building drugs, devices and novel therapeutics

Free webinar: July 21 | 10 - 11:15am ET
Hosted by the Women in Eye and Vision Research (WEAVR) Committee

This webinar will provide an exploration of topics relating to development of ophthalmic therapies, with applications of conventional drugs or devices, and novel biologic therapeutics. Discussion of each panelist’s career journey, challenges and successes will give the audience a better understanding and appreciation of the scientific and regulatory process, and also provide insight for young scientists interested in a career in translational research or drug/device development.

Attendees of this webinar will:

  • Gain a better understanding of the drug/device/biologic development, including drug delivery, and clinical and regulatory process
  • Learn about academic and non-academic career choices
  • Learn from women who have had diverse careers in the vision sciences (as entrepreneurs or clinician-scientists in industry, academics or government) about the important career decisions they made to excel in their respective endeavors.

This webinar is provided at no charge and hosted by ARVO's Women in Eye and Vision Research (WEAVR) Committee. A Certificate of Attendance will be available to all attendees.

register today button

 

Moderators & Organizers

Kathryn CrawfordKathryn S. Crawford, PhD
CEO, PharmOcu, LLC



Neena HaiderNeena B. Haider, PhD
Associate Professor of Ophthalmology, Harvard Medical School/ SERI-MEEI



Stella RobertsonStella M. Robertson, PhD
Co-founder, Bios Partners, LP
Owner, Arrochar Consulting LLC
Chair WEAVR Leadership Committee
 

Speakers

Shikha BarmanBuilding a Translational Company: Bioengineering Applied to Optimize Ocular Drug Delivery
Shikha Barman, PhD
CEO, Integral BioSystems, LLC
CEO and Founder, Integral Ophthalmics, LLC 

Patricia ZillioxFrom big pharma to non-profit, to startup:  Leading a novel biologic/device combination gene therapy company on both sides of the Atlantic
Patricia Zilliox, PhD
President and CEO, Eyevensys

Margot GoodkinFrom the bench, to the bedside, and everywhere in between: One Doctor’s Path through the Many Worlds of the Clinician-Scientist
Margot Goodkin, MD, PhD
Executive Director, Clinical Development, Allergan, an AbbVie Company

Ula JurkunasFrom Bench to Clinicals: developing new stem cell therapies and beyond
Ula Jurkunas, MD
Associate Professor, Ophthalmology, Harvard
(Schepens Eye Research Institute, MEEI)

Malvina EydelmanRegulatory Leadership in Medical Devices
Malvina B. Eydelman, MD
Director, Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices, CDRH, Food and Drug Administration